In September, Prolight conducted a business review at its contract manufacturing partner for the cartridge, FlexMedical Solutions (FMS) in Livingston, UK. The review included a progress update and an inspection of the pilot cartridge manufacturing line and associated support facilities.
“It was exciting to see the significant progress FMS has made over the last few months. With building works now complete, it was great to see the first wave of production equipment being installed” said COO Karl Bullen.
“We are very proud of our facilities and our team and as such it is always a privilege to host our clients. The dedicated Prolight production suite is really taking shape and we are excited to take receipt of the remaining manufacturing equipment in the coming months” said Murray Whyte, CTO.
The pilot line at FMS is being commissioned to support the regulatory approvals including the clinical performance study and volumes for commercial launch. With the ability to produce hundreds of thousands of cartridges at a competitive cost of goods, the technologies and processes being developed by FMS are designed to be scalable with future high levels of automation, thus enabling a swift transition to full-scale commercial production.
For further information, please contact:
Ulf Bladin, CEO
E-mail: ub@prolightdx.com
Phone: +46 73 582 39 87
Company website: www.prolightdx.com
About Us
Prolight Diagnostics AB develops innovative Point-of-Care (POC) systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood.
We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events. Our launch product will be for the measurement of troponin, to aid in the rule-in and rule-out of myocardial infarction.
The company’s share is traded on the NGM Nordic SME marketplace, under the ticker PRLD.